stopOverflowHandler
NEW PHARMACEUTICAL COMPOUNDS FOR TREATING MALARIA
Principal Investigator: Laurent Meijer

 

CONTEXT

Malaria is responsible each year for 250-300 million clinical cases leading to 1 to 3 millions deaths. Plasmodium falciparum is the parasite of malaria that causes most deaths but other species such as P. vivax, P. malariae, P. ovale, P. knowlesi contribute to malaria in various areas. P. falciparum is the most dangerous of these infections as P. falciparum malaria has the highest rates of complications and mortality. Due to worldwide increasing resistance of Plasmodium falciparum against drugs, there is a real need to develop new chemical structures with new biological pathways.


Pour lire la suite, merci de vous identifier ou de vous inscrire dans la zone de droite...
 
< Précédent   Suivant >
 
 

Identification






Direct Access
+33 1 40 51 00 90
BIO International Convention 2012

Rencontrez-nous du 18 au 21 juin 2012 à la Convention d’Affaires Internationale « BIO International ...
Details ...



Biovaria 2012, Munich, Germany 15th May 2012

The marketplace for life-science technologies from leading European research institutions and ...
Details ...



 
   
viagra 100mg